Showing results (1651-1660 of 1,715) with videos related to

Sort By:
Pageof 172
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 6, 2022
Polyvinylamine with moderate binding affinity as a highly effective vehicle for RNA deliveryYe Tian, Yipu Zhao, Chong Yin, et al.
JACC. Cardiovascular Interventions|January 24, 2018
Prognostic Implication of Functional Incomplete Revascularization and Residual Functional SYNTAX Score in Patients With Coronary Artery DiseaseKi Hong Choi, Joo Myung Lee, Bon-Kwon Koo, et al.
JACC. Cardiovascular Interventions|July 25, 2020
Role of Post-Stent Physiological Assessment in a Risk Prediction Model After Coronary Stent ImplantationDoyeon Hwang, Joo Myung Lee, Seokhun Yang, et al.
Circulation. Cardiovascular Interventions|September 8, 2020
Prognostic Impact of Residual Anatomic Disease Burden After Functionally Complete RevascularizationJoo Myung Lee, Doyeon Hwang, Ki Hong Choi, et al.
JACC. Cardiovascular Interventions|February 5, 2021
3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent ImplantationXiao-Fei Gao, Zhen Ge, Xiang-Quan Kong, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Ryanodine Receptor Inhibition with Dantrolene Prevents Ventricular Tachycardia Induction in Patients with Structural Heart Disease - A Randomized Controlled TrialMajd A El-Harasis, Zachary T Yoneda, Bibin Varghese, et al.
The American Journal of Pathology|April 25, 2015
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder CancerOpal L Reddy, Justin M Cates, Lan L Gellert, et al.
Circulation. Arrhythmia and Electrophysiology|July 25, 2025
2-Hydroxybenzylamine for Treatment of Atrial Fibrillation: A First-in-Human Clinical Pilot TrialZachary T Yoneda, Matthew O'Neill, Diane M Crawford, et al.
Pageof 172